Susceptibility to Infections in Ataxia Telangiectasia

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

July 31, 2016

Conditions
Ataxia TelangiectasiaInfectionsImmunodeficiencyLung Disease
Interventions
PROCEDURE

Blood collection

In all patients with Ataxia telangiectasia blood was collected at each visit date to determine blood count, lymphocyte subpopulation count and immunoglobulin levels in serum (IgA, IgG, IgM, IgE), as well as alpha feto protein (AFP).

PROCEDURE

Lung function measurement

In all patients - Ataxia telangiectasia and healthy controls - a lung function measurement was done to determine vital capacity (VC), forced expiratory volume in 1 second (FEV1), peak expiratory flow (PEF) and Tiffenau index.

BEHAVIORAL

Symptom diary

All patients - Ataxia telangiectasia and healthy controls - were requested to keep a symptom diary for the months September to March of the years 2012/2013 and 2013/2014 to determine days with symptoms as coughing during day and night, cold and fever, as well missing days at kindergarten/school/work, intake of medication (especially antibiotic treatment) and hospitalisations.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

CSL Behring

INDUSTRY

lead

Johann Wolfgang Goethe University Hospital

OTHER